ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,681.20
      -2.17%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.245
      0.16%
      Bitcoin
      57,104.91
      -0.43%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Rhythm Pharmaceuticals Inc (RYTM)

      7. Rhythm Pharmaceuticals Inc (RYTM) News

      RYTM

      Rhythm Pharmaceuticals (RYTM)

      Rhythm Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:RYTM
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      06/22/20228:00AMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces that European Commission Authorized Variation for IMCIVREE® (setmelanotide) to Allow for Dosing in Patients with POMC or LEPR deficiency with Renal ImpairmentNASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/17/202212:06PMDow Jones NewsRhythm Pharma Higher After FDA Approves Supplemental NDANASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/16/20224:02PMGlobeNewswire Inc.Rhythm Pharmaceuticals Enters into a Non-dilutive Revenue Interest Financing Agreement with HealthCare Royalty for up to $100 MillionNASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/16/20224:01PMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Use in Patients with Bardet-Biedl SyndromeNASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/16/20223:01PMDow Jones NewsRhythm Pharmaceuticals Up 12%; Thursday Is PDUFA Goal DateNASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/14/20226:45AMTipRanksLadenburg Thalmann & Co. Thinks Rhythm Pharmaceuticals’ Stock is Going to RecoverNASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/13/20228:00AMGlobeNewswire Inc.Rhythm Pharmaceuticals Presents New Data from Long-term Extension Trial Evaluating Setmelanotide in Bardet-Biedl Syndrome or POMC or LEPR Deficiency Obesity at ENDO 2022NASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/13/20228:00AMGlobeNewswire Inc.Rhythm Pharmaceuticals Presents Initial Data from Long-term Extension Trial Evaluating Setmelanotide in Rare Genetic Diseases of Obesity at ENDO 2022NASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/10/20224:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/10/20224:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/10/20224:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/10/20224:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/10/20224:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/10/20224:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/10/20224:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/07/202212:30PMTipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Abbott Labs (ABT), Rhythm Pharmaceuticals (RYTM) and Arcutis Biotherapeutics (ARQT)NASDAQ:RYTMRhythm Pharmaceuticals Inc
      06/02/20224:01PMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
      05/24/202212:39PMTipRanksGoldman Sachs Keeps a Hold Rating on Rhythm Pharmaceuticals (RYTM)NASDAQ:RYTMRhythm Pharmaceuticals Inc
      05/05/20224:01PMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
      05/04/20228:00AMGlobeNewswire Inc.Rhythm Pharmaceuticals to Present at BofA Securities 2022 Healthcare ConferenceNASDAQ:RYTMRhythm Pharmaceuticals Inc
      05/03/20221:35PMTipRanksNeedham Thinks Rhythm Pharmaceuticals’ Stock is Going to RecoverNASDAQ:RYTMRhythm Pharmaceuticals Inc
      05/03/20227:00AMGlobeNewswire Inc.Rhythm Pharmaceuticals Reports First Quarter 2022 Financial Results and Business UpdateNASDAQ:RYTMRhythm Pharmaceuticals Inc
      05/02/20228:00AMGlobeNewswire Inc.Rhythm Pharmaceuticals Presents New Data from Phase 3 Trial Evaluating Setmelanotide in Patients with Bardet-Biedl Syndrome (BBS) at the Pediatric Endocrine Society (PES) 2022 Virtual Annual MeetingNASDAQ:RYTMRhythm Pharmaceuticals Inc
      04/26/20228:00AMGlobeNewswire Inc.Rhythm Pharmaceuticals to Report First Quarter 2022 Financial Results on Tuesday, May 3, 2022NASDAQ:RYTMRhythm Pharmaceuticals Inc
      04/08/20228:00AMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
      04/08/20226:55AMTipRanksRhythm Pharmaceuticals (RYTM) Gets a Buy Rating from NeedhamNASDAQ:RYTMRhythm Pharmaceuticals Inc
      04/07/20226:45AMTipRanksLadenburg Thalmann & Co. Reiterates a Buy Rating on Rhythm Pharmaceuticals (RYTM)NASDAQ:RYTMRhythm Pharmaceuticals Inc
      04/06/20228:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RYTMRhythm Pharmaceuticals Inc
      04/06/20228:00AMGlobeNewswire Inc.Rhythm Pharmaceuticals Optimizes Design of EMANATE and DAYBREAK Clinical Trials to Advance Setmelanotide for Rare Genetic Diseases of ObesityNASDAQ:RYTMRhythm Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:RYTM